loading...| Preferred Name |
nateglinide |
|
| Synonyms |
N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine |
|
| Definitions |
A condition in which the main influencing factor is nateglinide, an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0000684 |
|
| created_by |
slaulede |
|
| creation_date |
2020-04-30T14:19:39Z |
|
| database_cross_reference |
CHEBI:31897 |
|
| definition |
A condition in which the main influencing factor is nateglinide, an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus. |
|
| has_exact_synonym |
N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0000684 |
|
| label |
nateglinide |
|
| notation |
XCO:0000684 |
|
| prefLabel |
nateglinide |
|
| treeView | ||
| subClassOf |